Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“COVID-19 vaccine maker BioNTech is to close three sites in Germany after efforts to find buyers failed.”
VerifiedConfidence: HIGH

Reasoning

The supplied DW articles consistently report that BioNTech is closing three sites in Marburg, Idar-Oberstein, and Tübingen after unsuccessful attempts to sell them, matching the claim exactly.

On confidence: Multiple primary sources from DW citing Reuters and other agencies directly state BioNTech will close three German sites after failing to find buyers.

Important context

The closures affect around 1,800 employees and are part of a broader restructuring that also includes shutting down operations in Singapore.

Evidence

Supporting (4)

  • Tier 1 — Primary source
    Germany news: COVID vaccine maker BioNTech to close 3 sites

    Politics Germany Germany news: COVID vaccine maker BioNTech to close 3 sites Timothy Jones dpa, Reuters, AP, AFP, epd, KNA Published 09/28/2026 Published September 28, 2026 last updated 09/28/2026 last updated September 28, 2026 COVID-19…

  • Tier 1 — Primary source
    Germany news: COVID vaccine maker BioNTech to close 3 sites

    failing to find a buyer (FILE 20/01/2021) Image: BionTech/REUTERS Advertisement Skip next section What you need to know What you need to know COVID-19 vaccine maker BioNTech is to close three sites in Germany after efforts to find buyers…

  • Tier 1 — Primary source
    Germany news: COVID vaccine maker BioNTech to close 3 sites

    add DW as a Preferred Source on Google. Skip next section BioNTech to close German sites after sale efforts fail 09/28/2026 September 28, 2026 BioNTech to close German sites after sale efforts fail Richard Connor The biotechnology company…

  • Tier 1 — Primary source
    Germany news: COVID vaccine maker BioNTech to close 3 sites

    plans in May to sell the facilities as part of a restructuring of its manufacturing operations. BioNTech said its efforts to find buyers had been unsuccessful, citing a difficult market and investment environment. The company said it had…

Limitations

All evidence comes from a single news outlet (DW) aggregating other reports; no independent corporate press release was provided.

Last verified:
Sep 28, 2026, 10:50 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Germany news: COVID vaccine maker BioNTech to close 3 sites

Deutsche Welle · Timothy Jones